Lawsuits Likely as Federal Authorities Roll Back Longstanding Vaccine Guidelines

In a recent interview with Pharmaceutical Executive, Ron Lanton, partner, Lanton Law, discussed the unprecedented legal and policy challenges emerging from recent changes to federal vaccine recommendations. The interview can be seen here.

Previous
Previous

Can America's Retreat On mRNA Be Europe's Opportunity?

Next
Next

Lanton Law Speaks on Clinical Ops Teams Maintaining Clinical Trial Integrity